Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...
Barclays analyst Gena Wang raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $435 from $418 and keeps an Equal Weight rating ...
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...